Delivery Order HHSN271201700016I-75N95018F00005
Award Date
9/7/18
Potential Completion Date
4/30/20
Potential Value
$790K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
IIT Research Institute
Ultimate Awardee
Illinois Institute Of Technology
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $473,586.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract, which does not have a set-aside designation, is part of NINDS's Pharmacology and Toxicology for Therapeutics Program and supports preclinical research activities, including toxicology studies and safety assessments of potential...
This is a federal contract award issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The $224,716.00 contract is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) vehicle called the Pharmacology and Toxicology for Therapeutics Program, which has a total ceiling value...
This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to IIT Research Institute, a non-profit research and technology development organization, to conduct non-clinical safety assessments of acoziborole (SCYX-7158) to support human African trypanosomiasis (HAT) drug development. The $1,156,165.39 delivery order is under the "CRO Support for NCATS In Vitro and In...
This is a $2,567,101.00 delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to IIT Research Institute, a non-profit division of Illinois Institute of Technology. The contract is for preclinical drug testing services, including pharmacology, toxicology, and safety evaluations, to support Investigational New Drug applications across therapeutic areas such as cancer, neurology, and neglected diseases. The...
This is a $2,561,491.00 delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the IIT Research Institute, a non-profit research arm of the Illinois Institute of Technology. The contract supports preclinical drug testing services, including pharmacology, toxicology, and safety testing, to generate data for Investigational New Drug applications across therapeutic areas such as cancer, neurology, and...
This is a $2,495,455.00 delivery order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit contract research organization and division of the Illinois Institute of Technology. The contract is for non-clinical safety assessment of a covalent bi-tox compound to support a neuropathic pain indication. This delivery order is part of a larger $48.6 million multiple-award CRO Support for NCATS In Vitro and...
This is a delivery order awarded by the Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences (NCATS) to IIT Research Institute, a non-profit research arm of Illinois Institute of Technology. The $1,759,590.00 cost-plus-fixed-fee contract provides non-clinical safety assessment of drinabant, a cannabinoid receptor (CB-1) antagonist, for acute cannabinoid overdose. The work will be performed in Chicago, Illinois and is part of...
This federal contract award is for $201,969.00 and was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology. The contract is for non-GLP dose range finding (DRF) studies to be completed by December 2023. This appears to be a task order issued under IITRI's $174.5 million single-award Pharmacology and Toxicology for Therapeutics Program contract...
The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $1,523 firm fixed price delivery order contract to IIT Research Institute of Chicago, Illinois. This order is against IIT Research Institute's indefinite-delivery/indefinite-quantity prime contract vehicle for the Pharmacology and Toxicology for Therapeutics Program, which provides research support services. The scope of work under this order involves a kickoff meeting to support the program's...
This federal contract award, valued at $698,236.00, was issued to the Illinois Institute of Technology Research Institute (IITRI), a non-profit organization, by a U.S. government agency. The contract is a Definitive Contract with a Firm Fixed Price pricing type. It does not have a set-aside designation. IITRI is a preclinical contract research organization (CRO) that provides a wide range of services to pharmaceutical, biotechnology, and government clients, including the National Institutes of...